Laurent Chardonnet's Net Worth

$20.1 Million

Estimate Recalculated Nov 11, 2024 02:43AM EST

Who is Laurent Chardonnet?

Laurent Chardonnet has an estimated net worth of $20.1 Million. This is based on reported shares across multiple companies, which include INCYTE CORP, Prelude Therapeutics Inc, and Axcella Health Inc..

SEC CIK

Laurent Chardonnet's CIK is 0001329010

Past Insider Trading and Trends

2015 was Laurent Chardonnet's most active year for acquiring shares with 13 total transactions. Laurent Chardonnet's most active month to acquire stocks was the month of December. 2011 was Laurent Chardonnet's most active year for disposing of shares, totalling 25 transactions. Laurent Chardonnet's most active month to dispose stocks was the month of May. 2015 saw Laurent Chardonnet paying a total of $1,889,296.32 for 128,912 shares, this is the most they've acquired in one year. In 2014 Laurent Chardonnet cashed out on 266,726 shares for a total of $8,381,409.52, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

INCYTE CORP (INCY) Snapshot price: $60.96

VP Finance and Treasurer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
$55.13
-$8,764,688.32
2.9K
Scheduled
Mar 30
Form 4
+65.72%
1.15K
—
—
2.9K
Jan 8
Form 4
-54.00%
-2.06K
$54.00
-$111,132.00
1.75K
May 12
Form 4
—
0
$30.48
-$1,432,760.00
3.81K
May 2
Form 4
—
0
$37.76
-$5,608,956.22
3.19K
Feb 13
Form 4
+55.15%
1.14K
—
—
3.19K
Jan 21
Form 4
-60.00%
-3.03K
$22.94
-$1,315,045.60
2.02K
Sep 5 - Sep 9
Form 4
—
0
—
—
0
Feb 9
Form 4
—
0
$16.10
-$643,292.28
3.03K
Scheduled
Jul 5
Form 4
—
0
$15.55
-$630,655.20
3.03K
Scheduled
Jul 2
Form 4
-93.14%
-13.98K
$22.70
-$317,255.20
1.03K
May 1
Form 4
—
0
—
—
0
Jan 19
Form 4
—
0
$12.04
-$525,994.52
13.98K
Jun 21
Form 4
-27.66%
-5.34K
$19.55
-$104,455.65
13.98K
May 6
Form 4
—
0
$10.06
-$347,376.30
11.32K
Apr 8
Form 4
—
0
—
—
0
Jan 25
Form 4
-74.51%
-15.62K
$14.06
-$219,534.90
5.34K
Aug 9
Form 4
—
0
—
—
0
May 18
Form 4
—
0
—
—
0
Jan 21
Form 4
—
0
—
—
0
Jan 27
Form 4
+3,200.00%
8K
$2.71
$21,677.00
8.25K
Nov 20
Form 4
—
0
—
—
0
Feb 8
Form 4
—
0
—
—
0
Feb 12
Form 4
—
0
—
—
0
Jan 13
Form 3
—
0
—
—
0
No matching records found

Prelude Therapeutics Inc (PRLD) Snapshot price: $5.18

Chief Financial Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Mar 1
Form 4
+13.45%
5K
$5.50
$27,500.00
42.16K
May 23
Form 4
—
0
—
—
0
Feb 7
Form 4
—
0
—
—
0
Dec 21
Form 4
+38.65%
10K
$4.76
$47,600.00
35.87K
Dec 8
Form 4
+68.97%
10K
$4.23
$42,300.00
24.5K
Jun 1
Form 4
+81.25%
6.5K
$7.51
$48,815.00
14.5K
Mar 21
Form 4
—
0
—
—
0
Feb 15
Form 4
+166.67%
5K
$12.28
$61,400.00
8K
Dec 13
Form 4
—
0
—
—
0
Nov 29
Form 3
—
0
—
—
0
No matching records found

Axcella Health Inc. (AXLA) No price found

Chief Financial Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+70.97%
2.6K
$3.60
$9,363.60
6.27K
Oct 30 - Feb 9
Form 4
+451.13%
3K
$4.94
$14,820.00
3.67K
Jan 31
Form 4
∞
665
$4.93
$3,278.84
665
Jan 24 - Jan 27
Form 4
—
0
—
—
0
Dec 18
Form 3
—
0
—
—
0
No matching records found